ArticleCase reports in oncology

Scleroderma Secondary to Pembrolizumab: A Case Report and Review of 19 Cases of Anti-PD-1-Induced Scleroderma.

Stephanie Farrugia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.